SEQUENCIO
Live / Applied — Response to non-final action entered (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 13 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99494302
- Mark type
- Stylized text
- Filed
- 13 Nov 2025
- Attorney of record
- Daan G. Erikson
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for treatment of cancer; human vaccine preparations; anti-cancer preparations; anti-cancer agents; drugs for the treatment of cancer; drugs for medical purposes; medicines for human purposes; vaccines against cancer; anti-cancer drugs; therapeutic cancer vaccines; immunotherapeutic agent; biological preparations for the treatment of premalignant disease to prevent malignant transformation; biological preparations for the treatment of premalignant conditions
Owner
- Sequencio Therapeutics Company Limited, Hong Kong, HK
Prosecution history
- 02 Apr 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Apr 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Mar 2026 — NON-FINAL ACTION E-MAILED
- 23 Mar 2026 — NON-FINAL ACTION WRITTEN
- 23 Mar 2026 — ASSIGNED TO EXAMINER
- 13 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 13 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Nov 2025 — NEW APPLICATION ENTERED